NEAT 001 /ANRS 143 Randomised Trial

 

First line Raltegrivir (RAL) + Darunavir/ Ritonavir (DRV/r) is Non-inferior to Tenofovir/ Emtricitabine (TDF/FTC) + DRV/r

 

Randomised, open label, multicentre, parallel-group, non-inferiority, strategic trial

​

Phase III

​

15 countries Austria, Belgium, Denmark, France, Germany, UK, Greece, Hungary, Ireland, Netherlands, Poland, Spain, Sweden

78 sites